Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cyclosporine As a Second-line Treatment of Primary Autoimmune Hemolytic Anemia

NCT05057468 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05057468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05057468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cyclosporine As a Second-line Treatment of Primary Autoimmune Hemolytic Anemia
Lead sponsor
Assiut University
Phase
Phase 3
Overall status
Recruiting
Start date
October 20, 2021
Completion date
November 30, 2026
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

primary autoimmune hemolytic anemia